New monoterpene glycosides and phenolic compounds from Distylium racemosum and their inhibitory activity against ribonuclease H

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 10, 2011, Pages 2840-2844

  Kim, Jeong Ah ^a   Yang, Seo Young ^a   Wamiru, Anthony ^b,c   McMahon, James B ^b   Le Grice, Stuart F J ^b   Beutler, John A ^b   Kim, Young Ho ^a,b  

^a Chungnam National University   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

Distylium racemosum; Megastigmane glucoside; Monoterpene glycosides; Ribonuclease H

Indexed keywords

6'' O GALLOYLSALIDROSIDE; CHLOROGENIC ACID METHYLESTER; DISTYLOSIDE A; DISTYLOSIDE B; EPIGALLOCATECHIN; ISO DIHYDRODENDRANTHEMOSIDE A; MONOTERPENE GLYCOSIDE DERIVATIVE; PHENOL; RIBONUCLEASE H; SALIDROSIDE; SYRINGIN; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CORRELATION ANALYSIS; DISTYLIUM RACEMOSUM; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; ESCHERICHIA COLI; ESTERIFICATION; EVERGREEN; FLUORESCENCE RESONANCE ENERGY TRANSFER; HETERONUCLEAR MULTIPLE BOND CORRELATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IC 50; NUCLEAR OVERHAUSER EFFECT; PHYTOCHEMISTRY; PLANT LEAF; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY; STEREOCHEMISTRY;

ENZYME ACTIVATION; ENZYME INHIBITORS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GLYCOSIDES; HAMAMELIDACEAE; HIV-1; HIV-2; HUMANS; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; MONOTERPENES; PHENOLS; PLANT EXTRACTS; PLANT LEAVES; PLANT STEMS; RIBONUCLEASE H;

DISTYLIUM RACEMOSUM; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 79955552011     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.03.091     Document Type: Article

References (23)

1. K. Klumpp, and T. Mirzadegan Curr. Pharm. Des. 12 2006 1909
2. D.M. Himmel, S.G. Sarafianos, S. Dharmasena, M.M. Hossain, K. McCoy-Simandle, T. Ilina, A.D. Clark Jr., J.L. Knight, J.G. Julias, P.K. Clark, K. Krogh-Jespersen, R.M. Levy, S.H. Hughes, M.A. Parniak, and E. Arnold ACS Chem. Biol. 1 2006 702
3. E. Tramontano, F. Esposito, R. Badas, R. Di Santo, R. Costi, and P. La Colla Antiviral Res. 65 2005 117
4. R.K. Ko, S. Lee, C.-G. Hyun, and N.H. Lee Bull. Korean Chem. Soc. 30 2009 1376
5. 2V multilabel plate reader (Perkin-Elmer Life Sciences, Boston, MA). To assess the effect of the inhibitors, 1 μL of inhibitor in DMSO was added to the microplate well before adding the substrate and rt solutions. N-(3,4,5-Trihydroxybenzoyl)-1-naphthaldehyde hydrazone (KMMP) was used as a positive control in all assays.
6. M.A. Parniak, K.L. Min, S.R. Budihas, S.F.J. Le Grice, and J.A. Beutler Anal. Biochem. 322 2003 33
7. J.H. Cardellina II, M.H.G. Munro, R.W. Fuller, K.P. Manfredi, T.C. McKee, M. Tischler, H.R. Bokesch, K.R. Gustafson, J.A. Beutler, and M.R. Boyd J. Nat. Prod. 56 1993 1123
8. R 7.8 min, 3.5 mg).
9. N.S. Kumar, and M. Rajapaksha J. Chromatogr., A 1083 2005 223
10. J. Landtag, A. Baumert, T. Degenkolb, J. Schmidt, V. Wray, D. Scheel, D. Strack, and S. Rosahl Phytochemistry 60 2002 683
11. J.I. Kim, H.H. Kim, S. Kim, K.T. Lee, I.H. Ham, and W.K. Whang Arch. Pharm. Res. 31 2008 274
12. X. Zhu, X. Dong, Y. Wang, J. Peng, and S. Luo Helv. Chim. Acta 88 2005 339
13. U.-J. Youn, Q.C. Chen, W.-Y. Jin, I.-S. Lee, H.-J. Kim, J.-P. Lee, M.-J. Chang, B.-S. Min, and K.-H. Bae J. Nat. Prod. 70 2007 1687
14. 8Li, 399.2570).
15. 16 The peaks of hydrolysates were detected at 14.11 min for d-glucose and 8.21 min d-xylose, respectively. The retention times of the authentic samples (Sigma-Aldrich), after being treated in a similar manner, were 14.11 (d-glucose), 14.24 (l-glucose), 8.21 (d-xylose), and 8.66 min (l-xylose).
16. J.A. Kim, S.Y. Yang, J.-E. Koo, Y.-S. Koh, and Y.H. Kim Bioorg. Med. Chem. Lett. 20 2010 6703
17. T. Matsumura, T. Ishikawa, and J. Kitajima Tetrahedron 57 2001 8067
18. T. Ishikawa, M. Kudo, and J. Kitajima Chem. Pharm. Bull. 50 2002 501
19. T. Ishikawa, T. Takayanagi, and J. Kitajima Chem. Pharm. Bull. 50 2002 1471
20. 3-MeOH (9:1), to afford aglycones 2a (1.0 mg) and 3a (2.0 mg), respectively.
21. H. Otsuka, K. Kamada, C. Ogimi, E. Hirata, A. Takushi, and Y. Takeda Phytochemistry 35 1994 1331
22. Preparation of the (R)- and (S)-MTPA ester derivatives of compound 3a: Two portions (each 0.4 mg) of 3a were treated with either (S)-(+)-R- or (R)- (-)-R-methoxy-R(trifluoromethyl)phenylacetyl chloride (5.0 μL) in anhydrous pyridine (50.0 μL) at room temperature overnight. The reaction mixtures were purified over small silica gel columns with n-hexane-EtOAc (8:1) as the elution solvent, to afford the (R)- and (S)-MTPA ester derivatives of 3a, respectively. R-MTPA ester of 3a: δ 1.89 (1H, d, J = 14.0 Hz, H-2 ax), 1.26 (1H, d, J = 14.0 Hz, H-2 eq), 5.22 (1H, m, H-3), 1.83 (1H, m, H-4 ax), 1.53 (1H, m, H-4 eq), 1.29 (1H, m, H-5), 1.84 (1H, m, H-7 ax), 1.53 (1H, m, H-7 eq), 1.71 (1H, m, H-8 ax), 1.64 (1H, m, H-8 eq), 5.01 (1H, m, H-9), 1.25 (3H, J = 9.0 Hz, H-10), 1.84 (3H, s, H-11), 1.53 (3H, s, H-12), 0.85 (3H, J = 6.5 Hz, H-13). S-MTPA ester of 3a: δ 1.90 (1H, J = 14.0 Hz, H-2 ax), 1.33 (1H, d, J = 14.0 Hz, H-2 eq), 5.17 (1H, m, H-3), 1.67 (1H, m, H-4 ax), 1.41 (1H, m, H-4 eq), 1.30 (1H, m, H-5), 1.84 (1H, m, H-7 ax), 1.33 (1H, m, H-7 eq), 1.44 (1H, m, H-8 ax), 1.44 (1H, m, H-8 eq), 4.97 (1H, m, H-9), 1.31 (3H, J = 9.0 Hz, H-10), 0.79 (3H, s, H-11), 0.72 (3H, s, H-12), 0.62 (3H, J = 6.5 Hz, H-13).
23. C. Luo, W. Grigsby, N. Edmond, A. Easteal, and J. Al-Hakkak J. Appl. Polym. Sci. 117 2010 352